Cancer diagnoses can bring overwhelming distress, yet support for existential fear & anxiety is often limited.
A new study explores why some UK patients are turning to psilocybin to help them process, and how prohibition shapes their decision making.
drugscience.org.uk/h...
In one week, our Street Drugs Discussions series will take stock of five years of overdose prevention policy in the UK and highlight what needs to change next.
Don't miss your chance to register and join ⬇️
📆 13 March | 12–2pm GMT | 💻 Online
🔗 eventbrite.co.uk/e/s...
Results from Compass Pathways’ Phase 3 COMP360 trials suggest the millions of patients living with TRD may be one step closer to a new treatment option.
Our new blog breaks down the data and what we should expect next in the regulatory process.
drugscience.org.uk/c...
"[MDMA] has this added feature that makes it a drug that has to be very carefully dealt with... You need facilitators in the room who will respond to it appropriately or will not let their own boundaries be disrupted by what's going on in the session."
drugscience.org.uk/p...
Our reporting on festival substance use & harm-reduction continues 👇
What do workers really think about how substance-related incidents are handled? Frontline perspectives reveal why coordinated, welfare-first approaches are key to risk management.
drugscience.org.uk/p...
➡️ Learn more about the study: lnkd.in/d345KZSB
➡️ Check your eligibility: lnkd.in/dczEgJKY
Our strategic collaboration with University College London is now recruiting for its latest study ⬇️
Qualified clinicians are invited to take part in a systematic exploration of their own MDMA experience within a carefully controlled clinical environment 🔬 🧠
Prof. David Nutt describes 'On Drugs' as “one of the best books on psychedelics since Huxley.”
He sits down with the author Justin Smith-Ruiu for a candid convo about the early psychedelic experiences and cultural observations that inspired the work🎙️
drugscience.org.uk/p...
Thrilled to welcome another pioneer of psychedelic therapy to the MPWG!
Beautiful Space specialises in relationships & sexual wellbeing, supporting people through loss of connection, relationship challenges & life transitions.
Explore their work: beautifulspace.org/
In London on Feb 25?
Make sure to catch the free UK premiere of Quiet the Sirens, a powerful documentary following 3 firefighters living with PTSD as they seek healing through an innovative psychedelic-assisted therapy group.
Screening to be followed by a live Q&A. 🎬
eventbrite.com/e/qui...
Texas has committed $50 million to ibogaine research, positioning the state as a new major player in psychedelic science.
What does this signal about the future of psychedelic research funding in the U.S? We unpack the implications in the link below.
drugscience.org.uk/t...
Our next Street Drugs Discussions looks back on 5 years of overdose prevention policy in the UK.
From the first safer drug consumption facility in Glasgow to harm reduction in Northern Ireland, we'll unpack what’s changed, what’s stalled, & what's next.
eventbrite.co.uk/e/s...
Professor David Nutt founded Drug Science in part to help create the foundation for sensible and effective drug laws.
This long-form piece revisits his work on nicotine harm, MCDA, and what we lose when policy refuses to distinguish between levels of harm.
disobedientmargins.c...
Current drug policies promote harm, not solutions.
IPDC's new report shows how punitive approaches continue to drive pain & undermine the UN goals of peace, rights & development.
bit.ly/idpc-ungass-1...
The ACMD has published an updated review of ketamine use, harms, and its legal classification.
We explain why we broadly welcome their findings, and what must happen next if the government is serious about reducing ketamine-related harms.
drugscience.org.uk/a...
From early research on esketamine to leading the first EU-funded multi-site study on PAT, pioneer researcher Robert Schoevers has seen it all.
He joined the pod to talk esketamine, the realities of EU funding, and what it takes to bring therapies into mainstream healthcare.
drugscience.org.uk/p...
21 peer-reviewed articles.
86 expert authors.
One year of evidence on critical developments in psychedelics, cannabis, harm reduction, and drug policy worldwide.
We’ve summarised the key findings from DSPL in 2025 to help you stay on top of the debates defining 2026.
drugscience.org.uk/d...
A new study exposes "reverse spin bias" — a pattern where evidence of benefit is downplayed in academic conclusions, particularly for controversial treatments.
We explore how this practice can quietly derail evidence-based drug policy.
drugscience.org.uk/r...
With drug-related deaths at record levels, practical guidance grounded in neuroscience and public health is a key part of keeping people safer.
Dr Rayyan Zafar spoke to Metro about what the science tells us about reducing the long-term impact of repeated drug use.
metro.co.uk/2026/01/...
Important progress in language accessibility in psychedelic research👏
The 5D-ASC Rating Scale, which captures changes in consciousness induced by pharmacological and non-pharmacological methods and predicts clinical outcomes, is now available in Mandarin.
drugscience.org.uk/m...
We often talk about how drug laws restrict clinical research. But what about other areas of knowledge production?
A spotlight on research into mushroom-forming fungi in NZ shows how drug policy limits scientific advancement far beyond the clinic.👇
drugscience.org.uk/t...
#DYK When cocaine and alcohol are used together, your body creates a more toxic compound called cocaethylene.
Our latest blog shares a firsthand account of its health consequences, and why better education for healthcare professionals is urgently needed.
drugscience.org.uk/c...
Introducing How (Not) To Heal, a new alternative mental health community rethinking care beyond diagnosis.
📍Don't miss their first event on 3/2, hosted by Rose Cartwright.
DS Community Members can email community@drugscience.org.uk for 15% off tickets.
eventbrite.co.uk/e/m...
Forgot a Christmas present this year? Gift an exclusive night of art, science, & celebration at Elmore Court on 30/1 🎨 Expect intimate talks from Prof David Nutt and Bruce Parry, a live auction + an afterparty.
All funds go directly to support our work⬇️
uk.givergy.com/ELMOR...
....and we're live! 🎟️ 🎨
Place your bid to join us for an unforgettable night of art, music, and science on the beautiful grounds of Elmore Court on January 30.
Offers include GA tickets plus a premium overnight stay for two. ⏬
Bidding ends Jan 19.
uk.givergy.com/ELMOR...
As psychedelic interest grows, so do its ecological implications.
We spoke to Dr Anya Ermakova and Dr Sam Gandy about how rising demand and psychedelic tourism may be threatening the very plants and animals at the heart of psychedelic practices.
drugscience.org.uk/p...
Lab research with animals often raises eyebrows, but little is publicly understood about how it supports modern science.
Prof Emma Robinson takes us inside this world, confronting common myths and explaining its role in mental health research.
🎧 drugscience.org.uk/p...
Psychedelics are moving fast. Our theories and ethics need to keep up.
A new framework challenges the biopsychic model dominating current research by expanding what “set and setting” means in both clinical and community contexts.
Read now in DSPL📖
drugscience.org.uk/s...
Buzzing from an incredible day at PSYCH Symposium. Amazing to bring together a community so passionate about advancing psychedelic medicine — the energy in the room truly reflected the momentum driving the field forward.
Huge thanks to everyone who made it such a success ✨
Meet Simon Doherty, a journalist focused on harm reduction in club spaces. On the latest episode of the DSP, he exposes what he’s uncovered... from the lack of accessible, evidence-based info to how some clubs avoid adopting harm reduction practices. 👀
drugscience.org.uk/p...
